{"id":"https://openalex.org/W4387433382","doi":"https://doi.org/10.1210/jendso/bvad114.1172","title":"THU092 Characterizing Immune Checkpoint Inhibitor Induced Hypophysitis In A Large Urban Health Care System","display_name":"THU092 Characterizing Immune Checkpoint Inhibitor Induced Hypophysitis In A Large Urban Health Care System","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387433382","doi":"https://doi.org/10.1210/jendso/bvad114.1172"},"language":"en","primary_location":{"id":"doi:10.1210/jendso/bvad114.1172","doi":"https://doi.org/10.1210/jendso/bvad114.1172","is_oa":true,"landing_page_url":"https://doi.org/10.1210/jendso/bvad114.1172","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1210/jendso/bvad114.1172","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063165102","display_name":"Mahalya Gogerly-Moragoda","orcid":"https://orcid.org/0000-0001-6982-2078","observed_orcids":["https://orcid.org/0000-0001-6982-2078"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mahalya Gogerly-Moragoda","raw_affiliation_strings":["Department of Medical Education, Icahn School of Medicine at Mount Sinai , New York, NY , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Education, Icahn School of Medicine at Mount Sinai , New York, NY , USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076812355","display_name":"Umar Sharif Khawaja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Umar Sharif Khawaja","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024836260","display_name":"Khadeen Christi Cheesman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khadeen C Cheesman","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040375335","display_name":"Amanda Leiter","orcid":"https://orcid.org/0000-0001-9072-5512","observed_orcids":["https://orcid.org/0000-0001-9072-5512"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Leiter","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA","institution_ids":["https://openalex.org/I98704320"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070276458","display_name":"Emily J. Gallagher","orcid":"https://orcid.org/0000-0002-7920-8474","observed_orcids":["https://orcid.org/0000-0002-7920-8474"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily J Gallagher","raw_affiliation_strings":["Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai , New York, NY , USA","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":{"value":3100,"currency":"USD","value_usd":3100},"apc_paid":{"value":3100,"currency":"USD","value_usd":3100},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18342455,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8633000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8633000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.09510000050067902,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.031300000846385956,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/hypophysitis","display_name":"hypophysitis","score":0.875},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8299999833106995},{"id":"https://openalex.org/keywords/secondary-adrenal-insufficiency","display_name":"secondary adrenal insufficiency","score":0.9789999723434448},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.753000020980835},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9240000247955322},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.8650000095367432},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.8399999737739563},{"id":"https://openalex.org/keywords/tremelimumab","display_name":"tremelimumab","score":0.9599999785423279},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.5009999871253967},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.6700000166893005},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.5669999718666077},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.4490000009536743},{"id":"https://openalex.org/keywords/hypocalcemia","display_name":"hypocalcemia","score":0.503000020980835},{"id":"https://openalex.org/keywords/hypokalemia","display_name":"hypokalemia","score":0.5979999899864197},{"id":"https://openalex.org/keywords/hypomagnesemia","display_name":"hypomagnesemia","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9192354679107666},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.8615233898162842},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8341488838195801},{"id":"https://openalex.org/C2780194577","wikidata":"https://www.wikidata.org/wiki/Q4120169","display_name":"Hypophysitis","level":4,"score":0.7575935125350952},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5322093367576599},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5285909175872803},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4292922019958496},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.41328543424606323},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.22873741388320923},{"id":"https://openalex.org/C2777658017","wikidata":"https://www.wikidata.org/wiki/Q156871","display_name":"Pituitary gland","level":3,"score":0.10616862773895264},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.08656775951385498}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1210/jendso/bvad114.1172","doi":"https://doi.org/10.1210/jendso/bvad114.1172","is_oa":true,"landing_page_url":"https://doi.org/10.1210/jendso/bvad114.1172","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10554541","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10554541","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10554541/pdf/bvad114.1172.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Endocr Soc","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1210/jendso/bvad114.1172","doi":"https://doi.org/10.1210/jendso/bvad114.1172","is_oa":true,"landing_page_url":"https://doi.org/10.1210/jendso/bvad114.1172","pdf_url":null,"source":{"id":"https://openalex.org/S2735747656","display_name":"Journal of the Endocrine Society","issn_l":"2472-1972","issn":["2472-1972"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315851","host_organization_name":"Endocrine Society","host_organization_lineage":["https://openalex.org/P4310315851"],"host_organization_lineage_names":["Endocrine Society"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Endocrine Society","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3158213892","https://openalex.org/W7168028249","https://openalex.org/W4321781650","https://openalex.org/W7140307905","https://openalex.org/W4379283600","https://openalex.org/W4220760298","https://openalex.org/W7213328860","https://openalex.org/W3021934041","https://openalex.org/W2969350539","https://openalex.org/W2996347226"],"abstract_inverted_index":{"Abstract":[0],"Disclosure:":[1],"M.":[2],"Gogerly-Moragoda:":[3],"None.":[4,8,11,14],"U.":[5],"Sharif":[6],"Khawaja:":[7],"K.C.":[9],"Cheesman:":[10],"A.":[12],"Leiter:":[13],"E.J.":[15],"Gallagher:":[16],"Consulting":[17],"Fee;":[18],"Self;":[19],"Novartis":[20],"Pharmaceuticals,":[21],"Flare":[22],"Therapeutics,":[23],"Seagen,":[24],"SynDevRx.":[25],"INTRODUCTION":[26],"Over":[27],"the":[28,73,130,153,176,185,225,241,253,367,399,412,428],"past":[29],"decade,":[30],"immune":[31,47],"checkpoint":[32],"inhibitors":[33],"(ICIs)":[34],"have":[35,161],"transformed":[36],"cancer":[37,197],"therapy":[38],"in":[39,80,175,427,437],"multiple":[40,352],"tumor":[41,90,188,353],"types":[42],"and":[43,67,75,89,121,200,213,260,275,326,354,398,408,433],"improved":[44],"outcomes.":[45],"Endocrine":[46],"related":[48],"adverse":[49],"events":[50],"are":[51],"well":[52],"recognized":[53],"side":[54],"effects":[55],"of":[56,78,87,98,114,117,135,144,297,305,316,349,369,389,430],"ICIs.":[57],"ICI":[58,299,355,417],"induced":[59],"hypophysitis":[60,79,128,350,390,432],"is":[61],"potentially":[62,384],"life-threatening":[63],"if":[64],"not":[65],"identified":[66],"treated.":[68],"The":[69,262,283,419],"present":[70],"study":[71],"examines":[72],"incidence":[74],"presentation":[76,287],"characteristics":[77],"a":[81,85,95,105,303,346,386],"real-world":[82,342],"cohort":[83],"including":[84],"multitude":[86],"ICIs":[88,103,141],"types.":[91,356],"METHODS":[92],"We":[93],"conducted":[94],"retrospective":[96],"analysis":[97],"all":[99,377],"patients":[100,137,157,306,321,370,405],"treated":[101,139],"with":[102,140,166,183,252,271,291,363,391,395,406],"at":[104],"large":[106],"health":[107],"system":[108],"from":[109,142,416],"2011-2020.":[110],"Patient":[111],"demographics,":[112],"type":[113,116,189],"cancer,":[115],"ICI,":[118],"endocrine":[119],"symptoms":[120],"laboratory":[122],"values":[123],"were":[124,138,158,173,376],"collected":[125],"to":[126,160,286,402,423],"characterize":[127],"within":[129,294],"cohort.":[131],"RESULTS":[132],"A":[133,171],"total":[134],"1703":[136],"2011-2020":[143],"whom":[145,317],"32":[146,154],"(1.9%)":[147],"developed":[148],"clinically":[149],"apparent":[150],"hypophysitis.":[151],"Of":[152],"patients,":[155],"26":[156],"confirmed":[159],"secondary":[162,169],"adrenal":[163],"insufficiency":[164],"(AI),":[165],"6":[167],"possible":[168],"AI.":[170],"majority":[172],"diagnosed":[174],"outpatient":[177],"setting":[178,429],"(n=21,":[179,269],"66%).":[180],"For":[181],"those":[182],"hypophysitis,":[184],"most":[186,226,263,292,360],"common":[187,227,264],"was":[190,224,267,288,359,425],"melanoma":[191],"(n=12,":[192],"38%),":[193],"followed":[194,229],"by":[195,230],"lung":[196],"(n=9,":[198,222],"28%)":[199,223],"genitourinary":[201],"cancers":[202],"(n=8,":[203,273],"25%).":[204],"Combination":[205],"cytotoxic":[206],"T-lymphocyte-associated":[207],"protein":[208,217],"4":[209],"(CTLA-4)":[210],"inhibitor,":[211,220],"ipilimumab":[212,232,364],"programmed":[214,242],"cell":[215,243],"death":[216,244],"1":[218,246],"(PD-1)":[219],"nivolumab":[221,235],"regimen,":[228],"monotherapies":[231],"(n=6,":[233,236,239,313],"19%),":[234,237,240,314],"pembrolizumab":[238],"ligand":[245],"(PD-L1)":[247],"inhibitor":[248],"atezolizumab":[249],"(n=3,":[250],"9%),":[251],"remainder":[254],"on":[255,311,378],"durvalumab":[256,259],"or":[257,334],"combination":[258],"tremelimumab.":[261],"presenting":[265,293],"symptom":[266,409],"fatigue":[268],"66%)":[270],"headache":[272],"25%)":[274],"vision":[276],"changes":[277],"(n=2,":[278],"6%)":[279],"being":[280],"less":[281],"common.":[282],"median":[284],"time":[285],"5":[289],"months":[290,296,310,375,415],"12":[295],"starting":[298],"(n=24,":[300],"75%).":[301],"However,":[302],"subset":[304,368],"presented":[307,372],"after":[308,373],"18":[309,374],"treatment":[312],"none":[315],"received":[318],"ipilimumab.":[319],"Seven":[320],"underwent":[322],"cosyntropin":[323,424],"stimulation":[324],"tests":[325],"six":[327],"had":[328],"muted":[329,420],"responses,":[330],"despite":[331],"having":[332],"low":[333,347],"inappropriately":[335],"normal":[336],"ACTH":[337],"levels.":[338],"DISCUSSION":[339],"In":[340],"this":[341],"dataset,":[343],"we":[344],"found":[345],"percentage":[348],"across":[351],"Secondary":[357],"AI":[358],"commonly":[361],"seen":[362],"treatment.":[365],"Notably,":[366],"who":[371],"PD-1":[379],"/":[380],"PD-L1":[381],"inhibitors,":[382,397],"which":[383],"indicates":[385],"distinct":[387],"mechanism":[388],"these":[392,404,438],"agents":[393],"compared":[394],"CTLA-4":[396],"new":[400],"need":[401],"monitor":[403],"labs":[407],"review":[410],"beyond":[411],"initial":[413],"few":[414],"start.":[418],"cortisol":[421],"response":[422],"surprising":[426],"acute":[431],"warrants":[434],"further":[435],"investigation":[436],"patients.":[439],"Presentation:":[440],"Thursday,":[441],"June":[442],"15,":[443],"2023":[444]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2023-10-09T00:00:00"}